When faced with a Waldenström macroglobulinemia diagnosis, what determines the best treatment for YOU? In this 30-minute webinar, Dr. Jorge Castillo will review key factors that affect treatment decisions, emerging treatment research, and tips for partnering with your healthcare team.
Dr. Jorge Castillo is Clinical Director at the Bing Center for Waldenström Macroglobulinemia Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School. Learn more about Dr. Castillo, here.
Watch online on Tuesday, March 22 at 1 PM Eastern (10 AM PT, 12 PM CT) for a 30-minute virtual webinar and download the guide here before the webinar airs.
All webinars will be recorded and posted on our website following the presentation.
This program is brought to you by the Patient Empowerment Network. Funding is provided by an unrestricted educational grant from Pharmacyclics, an AbbVie Company, and Janssen Biotech, Inc.